BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 30733302)

  • 21. Surface antigen phenotypes of hematopoietic stem cells from embryos and murine embryonic stem cells.
    McKinney-Freeman SL; Naveiras O; Yates F; Loewer S; Philitas M; Curran M; Park PJ; Daley GQ
    Blood; 2009 Jul; 114(2):268-78. PubMed ID: 19420357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia.
    Iwasaki M; Liedtke M; Gentles AJ; Cleary ML
    Cell Stem Cell; 2015 Oct; 17(4):412-21. PubMed ID: 26387756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance.
    Ly M; Rentas S; Vujovic A; Wong N; Moreira S; Xu J; Holzapfel N; Bhatia S; Tran D; Minden MD; Draper JS; Hope KJ
    Cancer Res; 2019 Nov; 79(22):5799-5811. PubMed ID: 31519687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of CD11A on hematopoietic stem cells denotes the loss of long-term reconstitution potential.
    Fathman JW; Fernhoff NB; Seita J; Chao C; Scarfone VM; Weissman IL; Inlay MA
    Stem Cell Reports; 2014 Nov; 3(5):707-15. PubMed ID: 25418718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cell of origin and the leukemia stem cell in acute myeloid leukemia.
    Chopra M; Bohlander SK
    Genes Chromosomes Cancer; 2019 Dec; 58(12):850-858. PubMed ID: 31471945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia.
    Han YC; Park CY; Bhagat G; Zhang J; Wang Y; Fan JB; Liu M; Zou Y; Weissman IL; Gu H
    J Exp Med; 2010 Mar; 207(3):475-89. PubMed ID: 20212066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation.
    Park SM; Cho H; Thornton AM; Barlowe TS; Chou T; Chhangawala S; Fairchild L; Taggart J; Chow A; Schurer A; Gruet A; Witkin MD; Kim JH; Shevach EM; Krivtsov A; Armstrong SA; Leslie C; Kharas MG
    Cell Stem Cell; 2019 Jan; 24(1):153-165.e7. PubMed ID: 30472158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukemia cells impair normal hematopoiesis and induce functionally loss of hematopoietic stem cells through immune cells and inflammation.
    Cui P; Zhang Y; Cui M; Li Z; Ma G; Wang R; Wang N; Huang S; Gao J
    Leuk Res; 2018 Feb; 65():49-54. PubMed ID: 29306107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Syndecan-2 enriches for hematopoietic stem cells and regulates stem cell repopulating capacity.
    Termini CM; Pang A; Li M; Fang T; Chang VY; Chute JP
    Blood; 2022 Jan; 139(2):188-204. PubMed ID: 34767029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-99 regulates normal and malignant hematopoietic stem cell self-renewal.
    Khalaj M; Woolthuis CM; Hu W; Durham BH; Chu SH; Qamar S; Armstrong SA; Park CY
    J Exp Med; 2017 Aug; 214(8):2453-2470. PubMed ID: 28733386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential niche and Wnt requirements during acute myeloid leukemia progression.
    Lane SW; Wang YJ; Lo Celso C; Ragu C; Bullinger L; Sykes SM; Ferraro F; Shterental S; Lin CP; Gilliland DG; Scadden DT; Armstrong SA; Williams DA
    Blood; 2011 Sep; 118(10):2849-56. PubMed ID: 21765021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.
    Zhu XN; Wei YS; Yang Q; Liu HR; Zhi Z; Zhu D; Xia L; Hong DL; Yu Y; Chen GQ
    J Hematol Oncol; 2023 Feb; 16(1):9. PubMed ID: 36774506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expansive effects of aorta-gonad-mesonephros-derived stromal cells on hematopoietic stem cells from embryonic stem cells.
    Fu JR; Liu WL; Zhou YF; Zhou JF; Sun HY; Luo L; Zhang H; Xu HZ
    Chin Med J (Engl); 2005 Dec; 118(23):1979-86. PubMed ID: 16336834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MLL-AF9- and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C.
    Zhu N; Chen M; Eng R; DeJong J; Sinha AU; Rahnamay NF; Koche R; Al-Shahrour F; Minehart JC; Chen CW; Deshpande AJ; Xu H; Chu SH; Ebert BL; Roeder RG; Armstrong SA
    J Clin Invest; 2016 Mar; 126(3):997-1011. PubMed ID: 26878175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional reconstruction of human AML reveals stem cell origin and vulnerability of treatment-resistant MLL-rearranged leukemia.
    Zeisig BB; Fung TK; Zarowiecki M; Tsai CT; Luo H; Stanojevic B; Lynn C; Leung AYH; Zuna J; Zaliova M; Bornhauser M; von Bonin M; Lenhard B; Huang S; Mufti GJ; So CWE
    Sci Transl Med; 2021 Feb; 13(582):. PubMed ID: 33627486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA HOTAIR promotes the self-renewal of leukemia stem cells through epigenetic silencing of p15.
    Gao S; Zhou B; Li H; Huang X; Wu Y; Xing C; Yu X; Ji Y
    Exp Hematol; 2018 Nov; 67():32-40.e3. PubMed ID: 30172749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.
    Zhang L; Zhou Y; Chen K; Shi P; Li Y; Deng M; Jiang Z; Wang X; Li P; Xu B
    Target Oncol; 2017 Oct; 12(5):677-687. PubMed ID: 28710745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of CD90, CD96, CD117, and CD123 on different hematopoietic cell populations from pediatric patients with acute myeloid leukemia.
    Chávez-González A; Dorantes-Acosta E; Moreno-Lorenzana D; Alvarado-Moreno A; Arriaga-Pizano L; Mayani H
    Arch Med Res; 2014 May; 45(4):343-50. PubMed ID: 24751333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells.
    Christensen JL; Weissman IL
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14541-6. PubMed ID: 11724967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1β inhibits normal hematopoietic expansion and promotes acute myeloid leukemia progression via the bone marrow niche.
    Wang Y; Sun X; Yuan S; Hou S; Guo T; Chu Y; Pang T; Luo HR; Yuan W; Wang X
    Cytotherapy; 2020 Mar; 22(3):127-134. PubMed ID: 32024607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.